Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus

Lignende værker

• Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
  af: Ji, Linong, et al.
  Udgivet: (2013)
• Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks
  af: Diamant, Michaela, et al.
  Udgivet: (2012)
• DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
  af: Buse, John B., et al.
  Udgivet: (2010)
• Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
  af: Kadowaki, Takashi, et al.
  Udgivet: (2010)
• Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
  af: Seewoodhary, Jason, et al.
  Udgivet: (2010)